José Miguel Laffita-Mesa Selected Research

Therapeutics

1/2017

Prodromal spinocerebellar ataxia type 2: Prospects for early interventions and ethical challenges.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

José Miguel Laffita-Mesa Research Topics

Disease

4	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 01/2012
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 10/2014
2	Parkinson Disease (Parkinson's Disease) 01/2017 - 04/2012
1	Frontotemporal Dementia (Semantic Dementia) 01/2021
1	Dementia (Dementias) 01/2021
1	Prodromal Symptoms 01/2017
1	Polyneuropathies (Polyneuropathy) 01/2017
1	Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar) 04/2012
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 04/2012

Drug/Important Bio-Agent (IBA)

3	Ataxin-2IBA 01/2013 - 01/2012
1	ProgranulinsIBA 01/2021
1	Levodopa (L Dopa)FDA LinkGeneric 01/2017
1	Methionine (L-Methionine)FDA Link 01/2017
1	DNA (Deoxyribonucleic Acid)IBA 10/2014
1	Adenine FDA LinkGeneric 04/2012
1	CytosineIBA 04/2012
1	GuanineIBA 04/2012

Therapy/Procedure

1	Therapeutics 01/2017